Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vyome Holdings, Inc. (HIND) vs Tempest Therapeutics, Inc. (TPST)

Vyome Holdings, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Vyome Holdings, Inc. and Tempest Therapeutics, Inc. are of similar size ($14.5M and $14.4M). Tempest Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Vyome Holdings, Inc. grew revenue faster over the last twelve months: 103.8% against −53.0%. Tempest Therapeutics, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Vyome Holdings, Inc. leads on 8 and Tempest Therapeutics, Inc. on 6.

Valuation

Metric HIND TPST Biotechnology median
P/E 0.00 n/m 7.88
P/S 110.31 39.00 11.47
P/B 1.96 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 78.55 52.83 10.73
Earnings yield 74,921.03% (515.66%) (28.84%)
Free cash flow yield (38.96%) (167.50%) (23.03%)

Profitability

Metric HIND TPST Biotechnology median
Gross margin 52.77% 0.00% 65.16%
Operating margin (9,184.82%) 0.00% 0.00%
Net margin (8,711.71%) 0.00% 0.00%
Free cash flow margin (4,298.00%) 0.00% 0.00%
Return on equity (172.10%) (931.14%) (57.72%)
Return on assets (124.23%) (237.25%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HIND TPST Biotechnology median
Revenue growth (TTM) 103.81% (52.98%) 5.64%
EPS growth (last fiscal year) 99.92% 67.55% —
Revenue growth, 5-year CAGR (50.98%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 0.38 4.73
Net debt to EBITDA 0.48 0.29 0.96

Dividend

Metric HIND TPST Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HIND TPST Biotechnology median
Market cap 14.46m 14.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack